2009Chinese Journal of Laser Medicine & SurgeryRequires access

Treatment of Diabetic Neovascular Glaucoma by Transscleral Cyclophotocoagulation and Retinal Photocoagulation

Shuyu Yang

Open publisher page 0 citations

Abstract

Objective To observe the clinical results of transscleral diode laser cyclophotocoagulation and retinal photocoagulation for diabetic neovascular glaucoma.Methods Twelve cases(13 eyes) of diabetic neovascular glaucoma were treated by transscleral diode laser cyclophotocoagulation and retinal photocoagulation.All patients were followed up 6-12 months.The intraocular pressure(IOP),visual acuity and neovascularization of the iris after 6 months of treatment were analyzed.Results Pre-treatment IOP was 32-68 mmHg(1 mmHg=0.133 kPa),averaged 46.56 mmHg.Six months after treatment,IOP was 8-27 mmHg,averaged 13.18 mmHg.Visual acuity decreased in 2 eyes,increased in 4 eyes and remained unchanged in 7 eyes.Neovascularization of the iris disappeared in 7 eyes and regressed partly in 6 eyes.Conclusions The treatment of diabetic neovascular glaucoma by diode laser cyclophotocoagulation and retinal photocoagulation can reduce IOP and save visual acuity.It is a safe,simple and effective method.

About this research paper

What this paper is about

Objective To observe the clinical results of transscleral diode laser cyclophotocoagulation and retinal photocoagulation for diabetic neovascular glaucoma.Methods Twelve cases(13 eyes) of diabetic neovascular glaucoma were treated by transscleral diode laser cyclophotocoagulation and retinal photocoagulation.All patients were followed up 6-12 months.The intraocular pressure(IOP),visual acuity and neovascularization of the iris after 6 months of treatment were analyzed.Results Pre-treatment IOP was 32-68 mmHg(1 mmHg=0.133 kPa),averaged 46.56 mmHg.Six months after treatment,IOP was 8-27 mmHg,averaged 13.18 mmHg.Visual acuity decreased in 2 eyes,increased in 4 eyes and remained unchanged in 7 eyes.Neovascularization of the iris disappeared in 7 eyes and regressed partly in 6 eyes.Conclusions The treatment of diabetic neovascular glaucoma by diode laser cyclophotocoagulation and retinal photocoagulation can reduce IOP and save visual acuity.It is a safe,simple and effective method.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical results of transscleral diode laser cyclophotocoagulation and retinal photocoagulation for diabetic neovascular glaucoma.Methods Twelve cases(13 eyes) of diabetic neovascular glaucoma were treated by transscleral diode laser cyclophotocoagulation and retinal photocoagulation.All patients were followed up 6-12 months.The intraocular pressure(IOP),visual acuity and neovascularization of the iris after 6 months of treatment were analyzed.Results Pre-treatment IOP was 32-68 mmHg(1 mmHg=0.133 kPa),averaged 46.56 mmHg.Six months after treatment,IOP was 8-27 mmHg,averaged 13.18 mmHg.Visual acuity decreased in 2 eyes,increased in 4 eyes and remained unchanged in 7 eyes.Neovascularization of the iris disappeared in 7 eyes and regressed partly in 6 eyes.Conclusions The treatment of diabetic neovascular glaucoma by diode laser cyclophotocoagulation and retinal photocoagulation can reduce IOP and save visual acuity.It is a safe,simple and effective method.

Key concepts: Medicine, Ophthalmology, Neovascular glaucoma, Intraocular pressure, Glaucoma, Retinal, Visual acuity, Diabetic retinopathy

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment of Diabetic Neovascular Glaucoma by Transscleral Cyclophotocoagulation and Retinal Photocoagulation — Research Paper | ScholarLens